Vise Technologies Inc. Acquires Shares of 13,406 Danaher Corporation $DHR

Vise Technologies Inc. acquired a new position in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 13,406 shares of the conglomerate’s stock, valued at approximately $2,554,000.

Several other large investors also recently made changes to their positions in DHR. Main Street Group LTD bought a new position in shares of Danaher in the first quarter valued at about $25,000. N.E.W. Advisory Services LLC bought a new stake in Danaher during the 2nd quarter worth about $25,000. JPL Wealth Management LLC bought a new stake in Danaher during the 3rd quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in shares of Danaher in the fourth quarter worth about $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 1.6%

Shares of NYSE:DHR opened at $219.42 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market cap of $154.25 billion, a price-to-earnings ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a 50 day moving average of $195.80 and a 200-day moving average of $192.61. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the business posted $0.77 earnings per share. Danaher’s revenue was up 5.5% compared to the same quarter last year. On average, sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on DHR shares. Royal Bank Of Canada upped their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Guggenheim reduced their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Stifel Nicolaus decreased their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Citigroup initiated coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

View Our Latest Stock Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.